BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.7994
-0.0096 (-1.19%)
At close: Jul 25, 2025, 4:00 PM
0.8000
+0.0006 (0.08%)
After-hours: Jul 25, 2025, 7:41 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $5.34 million as of July 25, 2025. Its market cap has decreased by -71.59% in one year.
Market Cap
5.34M
Enterprise Value
-7.70M
1-Year Change
-71.59%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $5.34M, a decrease of -79.46%. That is a compound annual growth rate of -30.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 5.50M | -78.00% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 715.94B |
| Johnson & Johnson | 403.74B |
| AbbVie | 336.23B |
| Novo Nordisk | 295.77B |
| UnitedHealth Group | 260.96B |
| Novartis AG | 224.80B |
| AstraZeneca | 216.82B |
| Abbott Laboratories | 216.42B |